Author
Shreyans Gandhi
Also Known As
S Gandhi, S. Gandhi, Shreyans A Gandhi, Shreyans A. Gandhi, Shreyans Gandhi, Simona Pagliuca, a rare chronic blood disorder. Ravulizumab provides the same clinical benefit as eculizumab in patients with PNH at a longer dosing interval (every 8 weeks [q8w] vs every 2 weeks [q2w]). Approximately 10%–15% of patients with PNH who receive the approved
82
Publications
1.3K
Citations
19
H-Index
16
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 3 | 3 | 181 |
2 | Immunology | 2 | 2 | 106 |
3 | Engineering | 1 | 1 | 29 |
4 | Applied Physics | 1 | 1 | 29 |
5 | Electrical Engineering | 1 | 1 | 29 |
Shreyans Gandhi
×
20
Publications
1K
Citations
16
H-Index
| Year | Citations | |
|---|---|---|
2014 | 249 | |
2024 | 119 | |
2024 | 85 | |
2019 | 83 | |
2009 | 75 | |
2021 | 64 | |
2018 | 59 | |
2020 | 51 | |
2023 | 39 | |
2011 | 29 |
Page 1
Page 1